178

Immunology & Rheumatology
Focuses on rheumatic and immune diseases.
Sub Categories on Immunology & Rheumatology
Latest Articles
Canadian wildfire smoke associated with increased asthma cases in NYC

Canadian wildfire smoke associated with increased asthma cases in NYC

by Elizabeth Lin,Yale UniversityCredit: Yale UniversityWith smoke from Canadian wildfires once againdescending on the Northeastern United States,residents of New England and New York

Canadian wildfire smoke associated with increased asthma cases in NYC

by Elizabeth Lin,Yale UniversityCredit: Yale UniversityWith smoke from Canadian wildfires once againdescending on the Northeastern United States,residents of New England and New York
Can science take the STING out of runaway inflammation?

Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res

Can science take the STING out of runaway inflammation?

by Cincinnati Children's Hospital Medical CenterGraphical abstract. Credit:Cell Reportsand Cincinnati Children'sUntil the COVID-19 pandemic exploded, few people outside of res
Study reveals way to predict side-effect risk from common immune suppressant medication

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s

Study reveals way to predict side-effect risk from common immune suppressant medication

by University of NottinghamMethotrexate (MTX) is an anti-metabolite most commonly used in chemotherapy and immunosuppressant in auto-immune diseases. Credit: University of NottinghamA major new s
CRP levels potentially useful in chronic spontaneous urticaria

CRP levels potentially useful in chronic spontaneous urticaria

(HealthDay)—C-reactive protein (CRP) levels are frequently elevated in patients with chronic spontaneous urticaria (CSU), and these elevations are relevant and potentially useful in management of the

CRP levels potentially useful in chronic spontaneous urticaria

(HealthDay)—C-reactive protein (CRP) levels are frequently elevated in patients with chronic spontaneous urticaria (CSU), and these elevations are relevant and potentially useful in management of the
Study examines the course of back pain over time

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of

Study examines the course of back pain over time

by WileyCredit: CC0 Public DomainBack pain is among the most frequently reported health problems in the world. New research published inArthritis Care & Research, an official journal of
How do I know if I need a cortisone shot?

How do I know if I need a cortisone shot?

by Carrie MacMillan,Yale UniversityCredit: Unsplash/CC0 Public DomainIf you're an athlete prone to overuse injuries or if you have a chronic condition like arthritis, chances are you've

How do I know if I need a cortisone shot?

by Carrie MacMillan,Yale UniversityCredit: Unsplash/CC0 Public DomainIf you're an athlete prone to overuse injuries or if you have a chronic condition like arthritis, chances are you've
Biological agent trials for psoriasis rarely include patient images

Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De

Biological agent trials for psoriasis rarely include patient images

by Elana GotkineFew randomized controlled trials involving biological agents for psoriasis treatment include patient images, according to a review published online on Nov. 15 in theJournal of De
Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these

Medication used to control blood sugar in people with type 2 diabetes may also reduce risk of autoimmune diseases

by American College of RheumatologyDipeptidyl peptidase-4 inhibitors commonly used to control blood sugar levels in people with type 2 diabetes may also reduce the risk of autoimmune diseases in these
The double face of RNase as a treatment for systemic autoimmune diseases

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste

The double face of RNase as a treatment for systemic autoimmune diseases

by Osaka UniversityThe RNA-degrading enzyme enhances the function of immune complexes formed by autoantibodies against Ro/SSA and La/SSB antigens. Credit: Ryota Naito et al. JCI Insight 2023Syste
Osteoarthritis biomarker could help cut $23 billion health bill

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful

Osteoarthritis biomarker could help cut $23 billion health bill

by Candy Gibson,University of South AustraliaCredit: Pixabay/CC0 Public DomainUniversity of South Australia researchers are a step closer to finding a new biomarker for osteoarthritis, a painful
VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages

VOYAGE phase 3: Dupilumab significantly reduced asthma exacerbations in children age 6-11

byAmerican Thoracic SocietyCredit: CC0 Public DomainResults from the VOYAGE study of dupilumab (Dupixent) showed that the monoclonal antibody significantly reduced exacerbations in children ages